$WRD

WeRide Inc.

1
2
0

No SEC Form 4 filings for $WRD in the last 30 days.

Med

WeRide Inc. Stock 12‑Month Price Target Cut to $13.89, Implies 95% Upside

WeRide Inc.'s average price target has been reduced from $14.23 to $13.89 by 11 analysts, with individual forecasts ranging from $10.98 to $20.92 per share. This new target suggests a potential upside of approximately 95% based on the May 20 closing price. The consensus rating from 16 analysts remains a "Buy."

[6-K] WeRide Inc. Current Report (Foreign Issuer) | WRD SEC Filing - Form 6-K

WeRide Inc. filed a Form 6-K Current Report with the SEC, detailing a repurchase of 765,000 WVR ordinary shares on May 21, 2026, for HKD 14,909,798. These repurchased shares will be held as treasury shares. The filing provides a detailed breakdown of the share capital changes and confirms compliance with relevant listing rules.

WeRide Repurchases Shares on Nasdaq Under Hong Kong-Approved Buyback Mandate

WeRide Inc. has repurchased 540,000 WVR ordinary A shares on Nasdaq for approximately $2.33 per share as part of a larger buyback mandate approved in March 2026. These shares are now held as treasury shares, reducing the number of issued shares excluding treasury shares and triggering a temporary moratorium on new share issues. Despite strong revenue rebound, TipRanks' AI analyst, Spark, rates WRD as Neutral due to ongoing losses, accelerating cash burn, and weak technicals, though the buyback and strong cash position offer some offset.